BioSpace News Archive

Business

BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights

BrainsWay Ltd. today reported third quarter 2023 financial results and provided an operational update.

November 15, 2023
·
14 min read
Business

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

Femasys Inc. today announced a strategic upfront investment of $6.85 million by public biotech company, PharmaCyte Biotech, Inc. (Nasdaq: PMCB) and other healthcare investors.

November 15, 2023
·
6 min read
Genetown

Velsera Launches Faster, Smarter Clinical Interpretation Workflows for Analyzing and Reporting on Genetic Sequence Data

Velsera is proud to introduce new capabilities for its Clinical Genomics Workspace (CGW) to streamline and transform the way clinical laboratory professionals interact with medical evidence and finalize complex molecular diagnostic reports.

November 15, 2023
·
3 min read
Business

CENTENE CORPORATION ANNOUNCES NEW CHIEF OPERATING OFFICER

Centene Corporation today announced the appointment of Susan Smith as its Chief Operating Officer (COO), effective January 1, 2024.

November 15, 2023
·
9 min read
Business

AIM ImmunoTech Reports Third Quarter 2023 Financial Results and Provides Clinical Pipeline Update

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported financial results for the third quarter 2023 and provided a business update.

November 15, 2023
·
4 min read
Cybin Announces Poster Presentation at Neuroscience 2023 Annual Meeting

Cybin Inc. today announced a poster presentation at Neuroscience 2023 hosted by the Society for Neuroscience (“SFN”) taking place November 11-15, 2022, in Washington, D.C.

November 15, 2023
·
6 min read
BioCapital

60 Degrees Pharma Announces Type C Meeting with FDA to Discuss Development of Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease

60 Degrees Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted a Type C meeting with the Company to consult on the path forward in developing the tafenoquine regimen of ARAKODA® for a potential indication in treating hospitalized babesiosis patients.

November 15, 2023
·
9 min read
IceCure Medical Files Appeal with U.S. FDA Requesting a Review of its De Novo Classification for ProSense® in Early-Stage Breast Cancer

IceCure Medical Ltd. today announced it has filed a request for supervisory review (“appeal”) under 21 CFR 10.75 with the U.S. Food and Drug Administration (“FDA”) regarding the agency’s denial of the Company’s De Novo Classification Request for treating patients with early-stage, low risk breast cancer.

November 15, 2023
·
6 min read
Business

Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2024

Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2024 financial results on Wednesday, December 6, 2023 after the close of trading.

November 15, 2023
·
3 min read
Business

MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results

MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the third quarter and the first nine months of 2023.

November 15, 2023
·
15 min read